Larvicides are insecticides used for killing mosquito larvae and pupae. The killing of mosquito larvae before they emerge as adults can reduce or eliminate the need for ground or aerial application of pesticides to kill adult mosquitoes. Moreover, larviciding can reduce the overall pesticide use in a control program.
The growth of the global larvicides market is primarily driven by the increasing prevalence of vector-borne diseases such as dengue, malaria, chikungunya, Zika, West Nile, and Lyme disease. According to the World Health Organization (WHO), vector-borne diseases account for more than 17% of all infectious diseases, causing over 700,000 deaths per year.
An estimated 216 million cases of malaria were reported in 91 countries and the deaths caused by malaria reached 445,000 in 2016. The WHO also stated that Africa was home to 90% of all malaria cases and 91% of malaria deaths in 2016.
Some of the manufacturers operating in the global larvicides market are Bayer AG (Germany), BASF SE (Germany), Syngenta (Switzerland), Sumitomo Chemical Co., Ltd (Japan), Adama Agan Ltd (Israel), Certis USA LLC (US), Central Garden & Pet Company (US), Nufarm Limited (Australia), Russell IPM Ltd (UK), Gowan Company (US), Isagro (Italy), and Arysta LifeScience Corporation (US)
To Receive Sample Copy Of Report, Click Here On Bellow Link:https://www.marketresearchfuture.com/sample_request/6360
The other prone regions include Asia, Latin America, the Middle East, and several parts of Europe. The adoption of the WHO Global Technical Strategy for Malaria by the World Health Assembly in May 2015, which provides a technical framework for all malaria-endemic countries, is expected to drive the demand for larvicides.
The strategy aims to reduce malaria case incidences and malaria mortality rates by at least 90% by 2030. It also aims to eliminate malaria in around 35 countries and prevent the resurgence of the disease in malaria-free countries. The outbreak of the Zika virus in Brazil in 2015 gained international attention. Prevention of such outbreaks is expected to drive the demand for larvicides in the coming years. Additionally, the increasing demand for larvicides in agricultural pest control is likely to fuel market growth.
The larvicides market has been analyzed with respect to five regions, namely, Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa.
The market in North America dominated the global larvicides market in 2017 on account of the increasing prevalence of vector-borne diseases in the region.
Increasing health awareness among citizens coupled with the high spending on healthcare in Europe is expected to drive product demand in the region during the forecast period.
The market in Asia-Pacific is expected to grow substantially due to the increasing prevalence of vector-borne diseases coupled with the high product demand in the agriculture industry in the region.
Review the summary and complete table of content@https://www.marketresearchfuture.com/reports/larvicides-market-6360
On the basis of type, the market has been segregated into liquids, tablets, pellets, granules, and briquettes. The liquid form of larvicides is highly preferred due to their ease of application and effectiveness.
Based on target, the market has been divided into mosquitoes and flies. The mosquitoes segment accounted for the majority market share in 2017 due to the high number of diseases carried by them such as chikungunya, dengue fever, lymphatic filariasis, Zika, malaria, Lyme disease, West Nile, and Chagas’ disease.
By application, the market has been segmented into public health, agriculture, commercial, residential, and livestock. The public health segment accounted for the largest market share in 2017. This can be attributed to climatic changes and population mobility resulting in favorable environments for pest growth.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar